- Home
- BBGI vs PHGE Comparison
BBGI vs PHGE Comparison
Compare BBGI & PHGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BBGI
- PHGE
- Stock Information
- Founded
- BBGI 1961
- PHGE 2015
- Country
- BBGI United States
- PHGE Israel
- Employees
- BBGI N/A
- PHGE N/A
- Industry
- BBGI Broadcasting
- PHGE Biotechnology: Pharmaceutical Preparations
- Sector
- BBGI Consumer Discretionary
- PHGE Health Care
- Exchange
- BBGI Nasdaq
- PHGE Nasdaq
- Market Cap
- BBGI 8.7M
- PHGE 7.8M
- IPO Year
- BBGI 2000
- PHGE N/A
- Fundamental
- Price
- BBGI $3.92
- PHGE $0.29
- Analyst Decision
- BBGI
- PHGE Strong Buy
- Analyst Count
- BBGI 0
- PHGE 1
- Target Price
- BBGI N/A
- PHGE $15.00
- AVG Volume (30 Days)
- BBGI 22.8K
- PHGE 1.8M
- Earning Date
- BBGI 11-10-2025
- PHGE 11-12-2025
- Dividend Yield
- BBGI N/A
- PHGE N/A
- EPS Growth
- BBGI N/A
- PHGE N/A
- EPS
- BBGI N/A
- PHGE N/A
- Revenue
- BBGI $220,174,714.00
- PHGE N/A
- Revenue This Year
- BBGI $5.02
- PHGE N/A
- Revenue Next Year
- BBGI N/A
- PHGE N/A
- P/E Ratio
- BBGI N/A
- PHGE N/A
- Revenue Growth
- BBGI N/A
- PHGE N/A
- 52 Week Low
- BBGI $3.67
- PHGE $0.25
- 52 Week High
- BBGI $10.42
- PHGE $1.16
- Technical
- Relative Strength Index (RSI)
- BBGI 38.63
- PHGE 30.74
- Support Level
- BBGI $3.71
- PHGE $0.25
- Resistance Level
- BBGI $4.04
- PHGE $0.29
- Average True Range (ATR)
- BBGI 0.36
- PHGE 0.04
- MACD
- BBGI -0.06
- PHGE -0.01
- Stochastic Oscillator
- BBGI 13.58
- PHGE 23.62
About BBGI Beasley Broadcast Group Inc.
Beasley Broadcast Group Inc is a multi-platform media company, whose primary business is operating radio stations throughout the United States. The company offers local and national advertisers integrated marketing solutions across audio, digital and event platforms. It owns and operates stations in the following markets: Atlanta, GA, Augusta, GA, Boston, MA, Charlotte, NC, Detroit, MI, Fayetteville, NC, Fort Myers-Naples, FL, Las Vegas, NV, Middlesex, NJ, Monmouth, NJ, Morristown, NJ, Philadelphia, PA, Tampa-Saint Petersburg, FL, and Wilmington, DE. The company operates in two segments Audio and Digital.
About PHGE BiomX Inc. COmmon Stock
BiomX Inc is engaged in developing both natural and engineered phage cocktails and personalized treatments designed to target and destroy harmful bacteria in chronic diseases, including cystic fibrosis and diabetic foot osteomyelitis. It discovers and validates proprietary bacterial targets and customizes phage compositions against these targets, and applies its BOLT (BacteriOphage Lead to Treatment) platform to customize phage compositions against these targets. BX004 is its therapeutic phage product candidate under development for chronic pulmonary infections caused by Pseudomonas aeruginosa, or P. aeruginosa, a main contributor to morbidity and mortality in patients with CF. Its BX211 - Treatment of Diabetic Foot Osteomyelitis (DFO).